Global Atovaquone and Proguanil market is expected to grow from US$ 146 million in 2025 to US$ 211 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.

Global Atovaquone and Proguanil Market Size and Outlook 2025-31

The global Atovaquone and Proguanil market size is predicted to grow from US$ 146 million in 2025 to US$ 211 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Atovaquone/Proguanil Hydrochloride is a dose combination of atovaquone and proguanil hydrochloride which acts as a blood schizonticide and also has activity against hepatic schizonts of Plasmodium falciparum. United States market for Atovaquone and Proguanil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Atovaquone and Proguanil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Atovaquone and Proguanil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Atovaquone and Proguanil players cover GSK, Glenmark, Mylan Pharmaceuticals, Hetero, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Atovaquone and Proguanil Industry Forecast looks at past sales and reviews total world Atovaquone and Proguanil sales in 2024, providing a comprehensive analysis by region and market sector of projected Atovaquone and Proguanil sales for 2025 through 2031. With Atovaquone and Proguanil sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atovaquone and Proguanil industry. This Insight Report provides a comprehensive analysis of the global Atovaquone and Proguanil landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Atovaquone and Proguanil portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Atovaquone and Proguanil market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atovaquone and Proguanil and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atovaquone and Proguanil. This report presents a comprehensive overview, market shares, and growth opportunities of Atovaquone and Proguanil market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; 250 mg/100 mg &nbsp;&nbsp;&nbsp; 62.5mg/25mg Segmentation by Application: &nbsp;&nbsp;&nbsp; Adult &nbsp;&nbsp;&nbsp; Paediatric This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; GSK &nbsp;&nbsp;&nbsp; Glenmark &nbsp;&nbsp;&nbsp; Mylan Pharmaceuticals &nbsp;&nbsp;&nbsp; Hetero Key Questions Addressed in this Report What is the 10-year outlook for the global Atovaquone and Proguanil market? What factors are driving Atovaquone and Proguanil market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Atovaquone and Proguanil market opportunities vary by end market size? How does Atovaquone and Proguanil break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Atovaquone and Proguanil Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Atovaquone and Proguanil by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Atovaquone and Proguanil by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Atovaquone and Proguanil Segment by Type &nbsp;2.2.1 250 mg/100 mg &nbsp;2.2.2 62.5mg/25mg &nbsp;2.3 Atovaquone and Proguanil Sales by Type &nbsp;2.3.1 Global Atovaquone and Proguanil Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Atovaquone and Proguanil Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Atovaquone and Proguanil Sale Price by Type (2020-2025) &nbsp;2.4 Atovaquone and Proguanil Segment by Application &nbsp;2.4.1 Adult &nbsp;2.4.2 Paediatric &nbsp;2.5 Atovaquone and Proguanil Sales by Application &nbsp;2.5.1 Global Atovaquone and Proguanil Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Atovaquone and Proguanil Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Atovaquone and Proguanil Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Atovaquone and Proguanil Breakdown Data by Company &nbsp;3.1.1 Global Atovaquone and Proguanil Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Atovaquone and Proguanil Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Atovaquone and Proguanil Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Atovaquone and Proguanil Revenue by Company (2020-2025) &nbsp;3.2.2 Global Atovaquone and Proguanil Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Atovaquone and Proguanil Sale Price by Company &nbsp;3.4 Key Manufacturers Atovaquone and Proguanil Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Atovaquone and Proguanil Product Location Distribution &nbsp;3.4.2 Players Atovaquone and Proguanil Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Atovaquone and Proguanil by Geographic Region &nbsp;4.1 World Historic Atovaquone and Proguanil Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Atovaquone and Proguanil Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Atovaquone and Proguanil Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Atovaquone and Proguanil Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Atovaquone and Proguanil Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Atovaquone and Proguanil Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Atovaquone and Proguanil Sales Growth &nbsp;4.4 APAC Atovaquone and Proguanil Sales Growth &nbsp;4.5 Europe Atovaquone and Proguanil Sales Growth &nbsp;4.6 Middle East & Africa Atovaquone and Proguanil Sales Growth 5 Americas &nbsp;5.1 Americas Atovaquone and Proguanil Sales by Country &nbsp;5.1.1 Americas Atovaquone and Proguanil Sales by Country (2020-2025) &nbsp;5.1.2 Americas Atovaquone and Proguanil Revenue by Country (2020-2025) &nbsp;5.2 Americas Atovaquone and Proguanil Sales by Type (2020-2025) &nbsp;5.3 Americas Atovaquone and Proguanil Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Atovaquone and Proguanil Sales by Region &nbsp;6.1.1 APAC Atovaquone and Proguanil Sales by Region (2020-2025) &nbsp;6.1.2 APAC Atovaquone and Proguanil Revenue by Region (2020-2025) &nbsp;6.2 APAC Atovaquone and Proguanil Sales by Type (2020-2025) &nbsp;6.3 APAC Atovaquone and Proguanil Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Atovaquone and Proguanil by Country &nbsp;7.1.1 Europe Atovaquone and Proguanil Sales by Country (2020-2025) &nbsp;7.1.2 Europe Atovaquone and Proguanil Revenue by Country (2020-2025) &nbsp;7.2 Europe Atovaquone and Proguanil Sales by Type (2020-2025) &nbsp;7.3 Europe Atovaquone and Proguanil Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Atovaquone and Proguanil by Country &nbsp;8.1.1 Middle East & Africa Atovaquone and Proguanil Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Atovaquone and Proguanil Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Atovaquone and Proguanil Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Atovaquone and Proguanil Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Atovaquone and Proguanil &nbsp;10.3 Manufacturing Process Analysis of Atovaquone and Proguanil &nbsp;10.4 Industry Chain Structure of Atovaquone and Proguanil 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Atovaquone and Proguanil Distributors &nbsp;11.3 Atovaquone and Proguanil Customer 12 World Forecast Review for Atovaquone and Proguanil by Geographic Region &nbsp;12.1 Global Atovaquone and Proguanil Market Size Forecast by Region &nbsp;12.1.1 Global Atovaquone and Proguanil Forecast by Region (2026-2031) &nbsp;12.1.2 Global Atovaquone and Proguanil Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Atovaquone and Proguanil Forecast by Type (2026-2031) &nbsp;12.7 Global Atovaquone and Proguanil Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 GSK &nbsp;13.1.1 GSK Company Information &nbsp;13.1.2 GSK Atovaquone and Proguanil Product Portfolios and Specifications &nbsp;13.1.3 GSK Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 GSK Main Business Overview &nbsp;13.1.5 GSK Latest Developments &nbsp;13.2 Glenmark &nbsp;13.2.1 Glenmark Company Information &nbsp;13.2.2 Glenmark Atovaquone and Proguanil Product Portfolios and Specifications &nbsp;13.2.3 Glenmark Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Glenmark Main Business Overview &nbsp;13.2.5 Glenmark Latest Developments &nbsp;13.3 Mylan Pharmaceuticals &nbsp;13.3.1 Mylan Pharmaceuticals Company Information &nbsp;13.3.2 Mylan Pharmaceuticals Atovaquone and Proguanil Product Portfolios and Specifications &nbsp;13.3.3 Mylan Pharmaceuticals Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Mylan Pharmaceuticals Main Business Overview &nbsp;13.3.5 Mylan Pharmaceuticals Latest Developments &nbsp;13.4 Hetero &nbsp;13.4.1 Hetero Company Information &nbsp;13.4.2 Hetero Atovaquone and Proguanil Product Portfolios and Specifications &nbsp;13.4.3 Hetero Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Hetero Main Business Overview &nbsp;13.4.5 Hetero Latest Developments 14 Research Findings and Conclusion

Report	Global Atovaquone and Proguanil Market Growth 2025-2031
Selected License	Multi ID: LPI25038

Buyer Information

Order Summary